BTIG analyst Ryan Zimmerman reiterated a Neutral rating and {REMOVEPT} price target on Hologic (NASDAQ: HOLX).The analyst commented: "We hosted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE